A Randomised, Double-blind, Placebo-controlled, Four-way Crossover, Repeat Dose Study Comparing the Effect of Inhaled Fluticasone Furoate/GW642444M Combination, GW642444M and Fluticasone Furoate on the Allergen-induced Asthmatic Response in Subjects With Mild Asthma.
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone furoate; Vilanterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Sep 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2010-019465-28).
- 07 Aug 2013 Results published in the Allergy.
- 19 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.